Platelet-to-lymphocyte ratio might predict the response to dupilumab treatment for patients with nasal polyposis.
Faris F BrkicDavid T LiuIris RücklingerNicholas James CampionTina Josefin BartosikErich VyskocilVictoria StanekAldine TuKatharina GanglSven SchneiderPublished in: Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale (2023)
The current study provides insights into the potential positive predictive value of the high PLR (> 131.2) in CRSwNP patients regarding treatment with dupilumab. There is a need for further prospective studies for validation of these results, especially in cohorts of patients with severe CRSwNP.